bioaccess®: Fast-Tracking First-in-Human Trials, Anywhere

bioaccess® is a US-based contract research organization (CRO) that specializes in accelerating early feasibility studies and first-in-human clinical trials for Medtech, Biopharma, and Radiopharma innovators. Founded by Dr. Pedro Martinez-Clark, the company addresses the challenges faced by early-stage Medtech companies by leveraging clinical research opportunities in Latin America, Eastern Europe, and Australia. These regions offer faster regulatory approvals, quicker patient enrollment, and lower costs compared to other areas. The company focuses on proof-of-concept, early feasibility, and pilot clinical trials, providing tailored solutions for Medtech startups. bioaccess® has a strong network of clinical research sites that enable rapid site activation and patient recruitment. Their mission is to improve healthcare access and outcomes by facilitating early access to innovative medical technologies and therapies, while also contributing to local economies through job creation and research promotion.

• Employees 20
• Founded 2010